home / stock / fwbi / fwbi quote
Last: | $2.84 |
---|---|
Change Percent: | 1.03% |
Open: | $2.87 |
Close: | $2.84 |
High: | $2.88 |
Low: | $2.65 |
Volume: | 38,061 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.84 | $2.87 | $2.84 | $2.88 | $2.65 | 38,061 | 04-18-2024 |
$2.9 | $2.93 | $2.9 | $3.0532 | $2.76 | 50,454 | 04-17-2024 |
$3.02 | $3.18 | $3.02 | $3.2975 | $2.97 | 63,012 | 04-16-2024 |
$3.27 | $3.46 | $3.27 | $3.55 | $3.15 | 34,733 | 04-15-2024 |
$3.32 | $3.54 | $3.32 | $3.55 | $3.25 | 41,067 | 04-12-2024 |
$3.4199 | $3.63 | $3.4199 | $3.63 | $3.3 | 17,543 | 04-11-2024 |
$3.42 | $3.7 | $3.42 | $3.7 | $3.39 | 33,333 | 04-10-2024 |
$3.65 | $3.73 | $3.65 | $3.775 | $3.5 | 25,328 | 04-09-2024 |
$3.78 | $3.98 | $3.78 | $4.0572 | $3.71 | 42,560 | 04-08-2024 |
$3.96 | $4.02 | $3.96 | $4.08 | $3.89 | 33,235 | 04-05-2024 |
$4.09 | $4.11 | $4.09 | $4.11 | $3.97 | 16,155 | 04-04-2024 |
$3.98 | $3.99 | $3.98 | $4.23 | $3.91 | 19,158 | 04-03-2024 |
$4.08 | $4.15 | $4.08 | $4.3 | $3.8714 | 27,280 | 04-02-2024 |
$4.24 | $4.58 | $4.24 | $4.58 | $4.04 | 63,119 | 04-01-2024 |
$4.38 | $3.99 | $4.38 | $4.55 | $3.85 | 70,539 | 03-29-2024 |
$4.38 | $3.99 | $4.38 | $4.55 | $3.85 | 70,539 | 03-28-2024 |
$3.95 | $4.04 | $3.95 | $4.1399 | $3.835 | 42,349 | 03-27-2024 |
$3.97 | $4.1 | $3.97 | $4.15 | $3.9 | 44,597 | 03-26-2024 |
$4.12 | $4.45 | $4.12 | $4.45 | $4 | 57,530 | 03-25-2024 |
$4.42 | $4.467 | $4.42 | $4.54 | $4.25 | 45,005 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
First Wave BioPharma Inc. Company Name:
FWBI Stock Symbol:
NASDAQ Market:
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a cli...
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...
BOCA RATON, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a cli...